Blood-brain barrier permeability and tPA-mediated neurotoxicity

被引:62
作者
Abu Fanne, Rami [2 ]
Nassar, Taher [1 ]
Yarovoi, Sergei [1 ]
Rayan, Anwar [3 ]
Lamensdorf, Itschak [4 ]
Karakoveski, Michael [5 ]
Vadim, Polianski [5 ]
Jammal, Mahmud [2 ]
Cines, Douglas B. [1 ]
Higazi, Abd Al-Roof [1 ,2 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Hebrew Univ Jerusalem, Dept Clin Biochem, Hadassah Med Ctr, Jerusalem, Israel
[3] QRC Qasemi Res Ctr, Baka El Garbiah, Israel
[4] Thrombotech Ltd, Ness Ziona, Israel
[5] PharmaSeed Ltd, Ness Ziona, Israel
基金
美国国家卫生研究院; 以色列科学基金会;
关键词
Stroke; Tissue type plasminogen activator (tPA); Blood-brain barrier; TISSUE-PLASMINOGEN ACTIVATOR; IN-VITRO; INHIBITOR; FIBRINOLYSIS; INFLAMMATION; ISCHEMIA; INFARCT; STROKE; INJURY; ACID;
D O I
10.1016/j.neuropharm.2009.12.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tissue type plasminogen activator (tPA) can induce neuronal apoptosis, disrupt the blood brain barrier (BBB), and promote dilation of the cerebral vasculature. The timing, sequence and contributions of these and other deleterious effects of tPA and their contribution to post-ischemic brain damage after stroke, have not been fully elucidated. To dissociate the effects of tPA on BBB permeability, cerebral vasodilation and protease-dependent pathways, we developed several tPA mutants and PAI-1 derived peptides constructed by computerized homology modeling of tPA. Our data show that intravenous administration of human tPA to rats increases BBB permeability through a non-catalytic process that is associated with reversible neurotoxicity, brain damage, mortality and contributes significantly to its brief therapeutic window. Furthermore, our data show that inhibiting the effect of tPA on BBB function without affecting its catalytic activity, improves outcome and significantly extends its therapeutic window in mechanical as well as in thromboembolic models of stroke. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:972 / 980
页数:9
相关论文
共 36 条
[1]   Protein data bank archives of three-dimensional macromolecular structures [J].
Abola, EE ;
Sussman, JL ;
Prilusky, J ;
Manning, NO .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :556-571
[2]  
Adelson PD, 1998, ACT NEUR S, V71, P104
[3]   LRP and αvβ3 mediate tPA activation of smooth muscle cells [J].
Akkawi, Sa'ed ;
Nassar, Taher ;
Tarshis, Mark ;
Cines, Douglas B. ;
Higazi, Abd Al-Roof .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (03) :H1351-H1359
[4]   BLOOD-BRAIN-BARRIER IN ALZHEIMER DEMENTIA AND IN NONDEMENTED ELDERLY - AN IMMUNOCYTOCHEMICAL STUDY [J].
ALAFUZOFF, I ;
ADOLFSSON, R ;
GRUNDKEIQBAL, I ;
WINBLAD, B .
ACTA NEUROPATHOLOGICA, 1987, 73 (02) :160-166
[5]   Neutralizing the neurotoxic effects of exogenous and endogenous tPA [J].
Armstead, William M. ;
Nassar, Taher ;
Akkawi, Saed ;
Smith, Douglas H. ;
Chen, Xiao-Han ;
Cines, Douglas B. ;
Higazi, Abd Al-Roof .
NATURE NEUROSCIENCE, 2006, 9 (09) :1150-1155
[6]   Plasminogen activators contribute to age-dependent impairment of NMDA cerebrovasodilation after brain injury [J].
Armstead, WM ;
Cines, DB ;
Higazi, AAR .
DEVELOPMENTAL BRAIN RESEARCH, 2005, 156 (02) :139-146
[7]   SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR KRINGLE-2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG [J].
BYEON, IJL ;
LLINAS, M .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 222 (04) :1035-1051
[8]   Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats [J].
Chen, JL ;
Sanberg, PR ;
Li, Y ;
Wang, L ;
Lu, M ;
Willing, AE ;
Sanchez-Ramos, J ;
Chopp, M .
STROKE, 2001, 32 (11) :2682-2688
[9]  
Chen Xuesong, 2008, J Neuroinflammation, V5, P12, DOI 10.1186/1742-2094-5-12
[10]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634